NCT02476630 - Thenar Tissue Oxygen Concentration (StO2): A Non-invasive Surrogate for Central Venous Oxygen Saturation (ScvO2) | Biotech Hunter

Enrollment

69

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions

Oxygen Concentration Levels

Interventions

DEVICE

StO2 measurement

All participants will have a measurement of the tissue oxygen concentration (StO2) level after applying the noninvasive probe to the thenar eminence. This measurement is done at the same time as a blood gas from the central venous catheter is obtained. The StO2 measurement is documented once for the subject in the study.

OTHER

Blood Gases

All participants will have a measurement of the tissue oxygen concentration (StO2) level after applying the noninvasive probe to the thenar eminence. This measurement is done at the same time as a blood gas from the central venous catheter is obtained. The StO2 measurement is documented once for the subject in the study.

Trial Locations (1)

32610

Shands Childrens Hospital UF Health, Gainesville